Cyient DLM :- About the company
Cyient DLM Ltd. is a subsidiary of Cyient Ltd., a Hyderabad-based industry-centric technology solutions company. The company was incorporated in 1993 to provide electronic manufacturing services (EMS).
Cyient DLM Ltd. is an integrated Electronic Manufacturing Services (EMS) and solution provider that focuses on a product’s life cycle, including design, manufacture, and maintenance. The company operates in diverse sectors like aerospace and defense, medical technology, and industrial sectors.The company’s extensive solutions comprise various vital components,including Printed Circuit Board (PCB),Printed Circuit Board assembly (PCBA), cable harnesses and Box builds.
Cyient DLM IPO Details :-
The Initial Public Offering (IPO) of Cyient DLM worth Rs.592 crore is set to open for subscription from Tuesday, Jun 27, 2023 and will remain open till Friday, Jun 30, 2023.
The public issue is completely fresh issue. The price band for the IPO is fixed at Rs.250 to Rs.265 per share. The minimum lot size for retail investors is 56 shares.
According to market observers, Mankind Pharma shares are available at a premium of Rs. 100 per equity share in the grey market today.
Cyient DLM IPO Details :-
| IPO DATE | Jun 27 , 2023 to Jun 30 ,2023 |
|---|---|
| Face Value | Rs. 10 per share |
| Price Band | Rs. 250 to Rs.265 per share |
| Lot Size (Min. Amount) | 56 shares (Rs.14,840/-) |
| Issuse Size | 22,339,623 shares(aggregating upto Rs.592 cr ) |
| Listing at | NSE , BSE |
| Lead Manager | Axis Capital Limited JM Financial Limited |
| Registrar | KFin Technologies Ltd. |
Cyient DLM IPO Tentative Dates:-
| EVENT | Tentative Date |
|---|---|
| Opening Date | Jun 27 , 2023 |
| Closing Date | Jun 30 , 2023 |
| Allotment Date | Jul 05 , 2023 |
| Initiation of Refund | Jul 06 , 2023 |
| Credit of Shares to demat | Jul 09 , 2023 |
| Listing Date | Jul 10 , 2023 |
Cyient DLM : Strengths & Weakness:-
Strengths:-
- The company has a robust and industry-leading order book with marquee customers.
- The company holds the distinction of being the largest supplier of EMS services to the aerospace and defense sector in India in terms of value.
- The company boasts a track record of long-term contracts with its customers, some even surpassing the 10-year mark.
- Over the past three years, the company witnessed significant growth. In 2022, the company’s total income amounted to Rs. 728.48 crores, a substantial increase from the Rs. 464.91 crores earned in 2020.
Weakness:-
- The company,s business is dependent on the sale of its products to certain key customers.
- The business of the company may be affected by any disruptions in the industry.
- The company’s business is highly dependent on import of raw material.
Cyient DLM : Financial Snapshots:-
| Particulars(in Rs. Crores) | FY-2023 | FY-2022 | FY-2021 | FY-2020 |
|---|---|---|---|---|
| Total Assests | 1.104.72 | 776.91 | 645.03 | 593.49 |
| Revenue from Operations | 838.34 | 728.48 | 636.91 | 464.91 |
| PAT | 31.73 | 39.80 | 11.81 | -6.70 |
| NET Worth | 197.87 | 77.11 | 37.65 | 25.71 |
| Reserve and Surplus | 145.01 | 75.75 | 36.29 | 24.34 |
| Debt | 314.47 | 293.19 | 233.77 | 261.37 |
How to apply for Cyient DLM IPO:-
After analyzing all the risks, strengths, and finances of the company.If you think you should apply for this IPO, here are the steps that you need to follow:
- Log into your Upstox account,using your six-digit PIN.
- After logging in , click on “Discover”
- On the “Discover” tab, you will find the “Invest in IPO” section.
- Under the “Invest in IPO” section, look for the ‘Cyient DLM IPO‘ tab and click on it.
- Now fill in all the required information, like ‘bid price’ and ‘lot size’.
- Confirm and click on “Apply”.
- Accept the mandate on your UPI app.
Hello,
We provide funding through our venture capital company to both start-up and existing companies either looking for funding for expansion or to accelerate growth in their company.
We have a structured joint venture investment plan in which we are interested in an annual return on investment not more than 10% ROI. We are also currently structuring a convertible debt and loan financing of 3% interest repayable annually with no early repayment penalties.
We would like to review your business plan or executive summary to understand a much better idea of your business and what you are looking to do, this will assist in determining the best possible investment structure we can pursue and discuss more extensively.
I hope to hear back from you soon.
Sincerely,
Tigran Ayrapetyan
Investment Director
Devcorp International W.L.L.
P.O Box 10236 Shop No. 305
Flr 3 Manama Centre, Bahrain
Email: ayrapetyantigran99@gmail.com
Hello.
Good cheer to all on this beautiful day!!!!!
Good luck 🙂
thanks for support